Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology

被引:33
|
作者
Hoyt, Clifford C. [1 ]
机构
[1] Akoya Biosci Inc, Malborough, MA USA
关键词
Predictive biomarkers; multiplex immunofluorescence; multispectral imaging; immuno-oncology; clinical workflow; image analysis; automated staining; spatial biology; LUNG-CANCER; EXPRESSION; ASSAY; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY; ASSOCIATION; NSCLC;
D O I
10.3389/fmolb.2021.674747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As immuno-oncology (I/O) emerges as an effective approach in the fight against cancer, multispectral imaging of multiplex immunofluorescence (mIF) is maturing as an analytical platform. The timing is fortuitous. Due to health economic considerations surrounding the use of I/O, there is an urgent need for tests that accurately predict response to the growing list of available therapies. Multispectral mIF provides several advantages over other biomarker modalities by enabling deeper interrogation of the intricate biology within the tumor microenvironment, including detection of cell-to-cell spatial interactions that correlate with clinical outcomes. It also provides a practical path for generating reliable and reproducible results in a clinically suitable, high-throughput workflow. In this article, we (1) describe the principles behind multispectral mIF; (2) provide advice and recommendations on assay development and optimization and highlight characteristics of a well-performing assay; and (3) discuss the requirements for translating this approach into clinical practice.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry
    Shakya, Reshma
    Tam Hong Nguyen
    Waterhouse, Nigel
    Khanna, Rajiv
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (10)
  • [22] Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
    Akturk, Guray
    Parra, Edwin R.
    Gjini, Evisa
    Lako, Ana
    Lee, J. Jack
    Neuberg, Donna
    Zhang, Jiexin
    Yao, Shen
    Laface, Ilaria
    Rogic, Anita
    Chen, Pei-Hsuan
    Sanchez-Espiridion, Beatriz
    Del Valle, Diane M.
    Moravec, Radim
    Kinders, Robert
    Hudgens, Courtney
    Wu, Catherine
    Wistuba, Ignacio I.
    Thurin, Magdalena
    Hewitt, Stephen M.
    Rodig, Scott
    Gnjatic, Sacha
    Tetzlaff, Michael T.
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5072 - 5083
  • [23] ImmunoGraft® platform for the evaluation of Immuno-Oncology agents in PDX tumors models
    Cerna, David
    Ciznadija, Daniel
    Verma, Bhavna
    Sidransky, David
    Izumchenko, Evgeny
    Davies, Angela
    Mancini, Maria
    CANCER RESEARCH, 2017, 77
  • [24] Development and validation of a screening platform for the identification of novel immuno-oncology targets
    Scoumanne, Ariane
    Rabolli, Virginie
    Legrand, Lea
    Martini, Murielle
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Cauwenberghs, Sandra
    Swiercz, Jakub
    CANCER RESEARCH, 2017, 77
  • [25] Organotypic tumor tissue slices provide versatile platform for immuno-oncology
    Sivakumar, Ramya
    Chan, Marina
    Yeung, Raymond
    Gujral, Taranjit S.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Molecular imaging in immuno-oncology: current status and translational perspectives
    Filippi, Luca
    Nervi, Clara
    Proietti, Ilaria
    Pirisino, Riccardo
    Potenza, Concetta
    Martelli, Olga
    Equitani, Francesco
    Bagni, Oreste
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (12) : 1199 - 1211
  • [27] Development of a Quantitative Systems Pharmacology (QSP) Platform to Support Translational Research and Clinical Development in Immuno-Oncology
    Schmidt, Brian J.
    Bartlett, Derek W.
    Agrawal, Shruti
    Reed, Michael
    Jure-Kunkel, Maria
    Gutierrez, Andres A.
    Clynes, Raphael A.
    Fischer, Bruce S.
    Surywanshi, Satyendra
    Kadambi, Ananth
    Friedrich, Christina
    Kudrycki, Katherine
    Roy, Amit
    Leil, Tarek A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S22 - S23
  • [28] Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects
    Antonia, Scott J.
    Larkin, James
    Ascierto, Paolo A.
    CLINICAL CANCER RESEARCH, 2014, 20 (24) : 6258 - 6268
  • [29] Challenges associated with the integration of immuno-oncology agents in clinical practice
    Patrice Lazure
    Aparna R. Parikh
    Neal E. Ready
    Marianne J. Davies
    Sophie Péloquin
    Jeffrey M. Caterino
    Robert Lewandowski
    Alexander J. Lazar
    Suzanne Murray
    BMC Medical Education, 22
  • [30] Immuno-oncology trends: preclinical models, biomarkers, and clinical development
    Franklin, Maryland Rosenfeld
    Platero, Suso
    Saini, Kamal S.
    Curigliano, Giuseppe
    Anderson, Steven
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)